Stock Events

Stock Events

Novacyt

€0.37

0

-€0.01-2.27% Tuesday 19:55

Statistics

Day High

0.37

Day Low

0.37

52W High

0.65

52W Low

0.37

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Upcoming

Earnings

30AprExpected

Q2 2022

Next

-0

0.33

0.67

1

Expected EPS

N/A

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NYZ.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. offers a range of products for the life science research and clinical diagnostics markets, competing directly with Novacyt's diagnostic solutions.

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, overlapping with Novacyt's offerings.

QIAGEN N.V. specializes in sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, directly competing with Novacyt's molecular diagnostic products.

Quest Diagnostics

Quest Diagnostics Incorporated offers diagnostic testing, information, and services, including COVID-19 testing, which competes with Novacyt's pandemic response products.

BioNTech SE operates in the biotechnology and pharmaceutical fields, developing therapies and vaccines, including for COVID-19, which places it in competition with Novacyt's diagnostic solutions for the pandemic.

Hologic, Inc. specializes in diagnostics, medical imaging systems, and surgical products, especially for women’s health, competing in the diagnostics market alongside Novacyt.

Abbott Laboratories

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products, including diagnostics that compete with Novacyt's portfolio.

Roche Holding AG focuses on pharmaceuticals and diagnostics. Its extensive diagnostics division directly competes with Novacyt in the field of infectious disease testing.

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services, with a diagnostics segment that competes with Novacyt.

AstraZeneca PLC, while primarily known for pharmaceuticals, has been involved in developing COVID-19 vaccines and related diagnostics, positioning it as a competitor in the pandemic response market where Novacyt operates.

About

Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. It operates in the United Kingdom, France, Europe, the United States, the Asia Pacific, the Middle East, and Africa. The company was incorporated in 2006 and is based in Le Vésinet, France.

Show more...

CEO

Mr. Lyn Dafydd Rees

Employees

234

Country

France

ISIN

FR0010397232

Listings

0 Comments

Share your thoughts

FAQ

What is Novacyt stock price today?▼

The current price of NYZ.STU is €0.37 EUR — it has decreased by -2.27% in the past 24 hours. Watch Novacyt stock price performance more closely on the chart.

What is Novacyt stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Novacyt stocks are traded under the ticker NYZ.STU.

Is Novacyt stock price growing?▼

NYZ.STU stock has fallen by -2.27% compared to the previous week, the month change is a -3.31% fall, over the last year Novacyt has showed a -18.42% decrease.

When is the next Novacyt earnings date?▼

Novacyt is going to release the next earnings report on April 30, 2026.

What were Novacyt earnings last quarter?▼

NYZ.STU earnings for the last quarter are -0 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.

How many employees does Novacyt have?▼

As of April 23, 2026, the company has 234 employees.

In which sector is Novacyt located?▼

Novacyt operates in the Health & Wellness sector.

When did Novacyt complete a stock split?▼

Novacyt has not had any recent stock splits.

Where is Novacyt headquartered?▼

Novacyt is headquartered in Le Vésinet, France.